America is living through a mental health emergency, and it is running out of the people trained to answer the call. Appointment backlogs stretch for months across much of the country, suicide rates remain stubbornly elevated, and community mental health clinics cannot fill vacant positions. Meanwhile, thousands of physicians who trained abroad — many already living and working in the United States — remain locked out of independent practice by a licensing system built on the assumption that only an American residency can produce a safe American doctor. Now a small but accelerating group of state legislatures is challenging that assumption, carving out alternative licensure pathways that could allow internationally trained physicians to practice psychiatry years earlier than the traditional route permits. A new commentary published June 8, 2026 in the journal Academic Psychiatry argues that these experiments are simultaneously long overdue and dangerously premature. Written by Manal Khan of the University of California, Los Angeles, with colleagues at the University of Pittsburgh Medical Center, Case Western Reserve University, Christiana Care Health System, and the University of Virginia, the paper maps both the potential of the new pathways and the pitfalls that could turn reform into a public health misstep.

The stakes are not abstract. The Centers for Disease Control and Prevention place mental health among the nation’s central public health challenges, estimating that more than one in five American adults lives with a mental illness in any given year. The Association of American Medical Colleges has repeatedly warned that its workforce projection models point to deep physician deficits, with mental health specialties among the hardest hit. The National Resident Matching Program described the 2025 Main Residency Match as the largest in history, yet competition for psychiatric training positions remains fierce and unfilled slots persist in the very communities that need psychiatrists most. International medical graduates, or IMGs, are not a marginal labor pool waiting on the sidelines. A 2022 analysis in Academic Psychiatry examined the role of IMGs in the United States psychiatry workforce, and a study published a quarter-century ago in the American Journal of Psychiatry found that internationally trained psychiatrists already displayed distinctive practice patterns, including disproportionate service in the public sector. During the COVID-19 pandemic, a study in JAMA Network Open documented deaths among IMG physicians in the United States — a grim measure of how far forward this workforce is already standing.

To understand why the state experiments matter, it helps to understand the machinery they are modifying. A foreign-trained physician seeking a full, unrestricted license in most US jurisdictions must clear a gauntlet of checkpoints: certification by the Educational Commission for Foreign Medical Graduates, a sequence of United States Medical Licensing Examination steps that tests basic science and clinical reasoning, and completion of an accredited residency — four years for psychiatry, from postgraduate year one through postgraduate year four — in a program overseen by the Accreditation Council for Graduate Medical Education. Only then do most state medical boards grant an unrestricted license, with board certification by the American Board of Psychiatry and Neurology functioning as an additional, examination-based credential layered on top. The architecture is deliberately designed as a uniform quality filter. Its critics answer that it is also a decade-long and financially punishing funnel that wastes trained talent: a psychiatrist can be fully licensed, experienced, and in good standing in another country yet legally barred from so much as supervised clinical work across much of the United States.

The counter-movement is now visible on the statute books. The Federation of State Medical Boards maintains a state-by-state chart of enacted and proposed additional licensure pathways for international medical graduates, and the commentary’s authors walk through the leading examples. In Tennessee, legislators amended Title 63 of the state code — the chapter governing the healing arts — through Senate Bill 1451, opening a route for foreign-trained physicians that does not run through the standard residency pipeline. In Virginia, administrative regulation 18VAC85-20-210 establishes “limited licenses to foreign medical graduates,” a category of restricted, supervised practice that permits internationally trained doctors to treat patients before completing a full American residency. These measures build on older infrastructure, most notably the federal Conrad 30 Waiver Program, which each year allows up to thirty physicians per state on J-1 exchange visas to forgo returning to their home countries in exchange for three years of service in federally designated health professional shortage areas. What is genuinely new is the idea of decoupling licensure itself from the completion of US residency training — a structural change rather than a visa adjustment.

The potential upside is what makes the moment electric. Internationally trained physicians are among the most reliable workforce instruments the country has for reaching underserved populations. Research published in the Journal of Health Care Poor Underserved showed that IMGs contribute substantially to diversity in the American physician workforce, and a 2021 commentary in The Lancet Gastroenterology & Hepatology argued that their role in advancing diversity has been chronically undervalued. Khan’s own earlier work in Academic Psychiatry made the case that supporting IMG physicians is one of the few realistic strategies for closing gaps in child psychiatry, one of the most severely underserved subspecialties in the country. A 2024 analysis in JAMA framed international medical graduates as an integral, permanent component of the physician workforce rather than a stopgap. Alternative licensure pathways could convert credentialed, experienced clinicians into practicing psychiatrists in rural counties and inner-city districts where recruitment has failed for decades — and patients who share linguistic and cultural backgrounds with their doctors consistently fare better in treatment engagement and follow-through.

But psychiatry is a moving target across borders, and this is where the technical difficulties begin. A 2021 comparative analysis in European Neuropsychopharmacology examined psychiatry training across forty-two European countries and found striking heterogeneity in program length, the balance between biological psychiatry and psychotherapy, supervision requirements, and examination standards. A worldwide survey of World Psychiatric Association member associations published in International Review Psychiatry reached a similar conclusion on a global scale. A foreign psychiatry residency, in other words, certifies very different things depending on where it was completed, and state medical boards currently possess no common metric for judging equivalency. One candidate solution is the entrustable professional activity, or EPA — a competency framework catalogued in a scoping review in Medical Education Online. Instead of counting months of training, an EPA-based assessment asks whether a physician can be trusted to perform defined clinical tasks unsupervised: conducting a suicide risk assessment, managing an acute psychotic crisis, prescribing psychotropic medication safely across populations. The World Federation for Medical Education’s Basic Medical Education Standards, oriented toward a 2030 horizon, offer a second possible benchmark — though they accredit medical schools, not the current competence of individual graduates.

The commentary’s treatment of unintended harms confronts a more uncomfortable variable: bias. A 2023 scoping review in BMJ Open documented pervasive perceptions of inequitable treatment among international medical graduates, spanning discrimination in selection, supervision, and everyday clinical hierarchies. That same year, a paper in Academic Pathology described a normalized “medical inferiority bias” and cultural racism against IMG physicians embedded within academic medicine itself. The irony is sharp: the presumption of inferiority coexists with decades of evidence that internationally trained doctors prop up exactly the services American medicine struggles to staff. The danger, as the authors frame it, is that poorly designed pathways could institutionalize a two-tier profession — limited-license physicians channeled into the least desirable posts, with lower pay, weaker legal protections, and no credible bridge to full licensure or board certification. Even existing board-level flexibility, such as the American Board of Psychiatry and Neurology’s academic pathway and the American Board of Radiology’s alternate certification routes, covers narrow niches rather than the general clinical workforce, leaving the structural question unresolved.

Then there is the question that animates every medical board hearing: is it safe? A 2025 analysis in the Journal of Graduate Medical Education examined the challenges of removing US residency training requirements for state licensure and found the technical problems thornier than the political rhetoric suggests — how to determine equivalency, how to verify training records across jurisdictions with different documentation cultures, and how to assess skills that may have diverged or eroded with time. A physician’s firsthand account of practicing within both the American and British systems, published in the British Journal of General Practice, illustrates how nontrivial those differences are even between two Anglophone countries with superficially similar medical cultures. The commentary’s authors do not argue for an open border in medical licensure; the architecture of their argument, with dedicated sections on standardization challenges and important considerations, points instead toward guardrails: mandatory supervised practice periods, standardized competency assessments, transparent equivalency criteria, and longitudinal outcome tracking that would let regulators learn from each state’s experiment rather than repeat its mistakes.

What happens next will test whether the United States can mount a coordinated national response to a workforce crisis, or whether it will improvise, state by state, as it usually does. The direction of the authors’ argument is clear: alternative pathways succeed only if they are engineered rather than merely enacted — anchored in validated competency assessments, harmonized across state lines, paired with the mentorship and integration support that resources from the American Psychiatric Association attempt to provide, and evaluated with real outcome data rather than anecdotes. Institutional scaffolding already exists in fragments. The American Medical Association has framed its advocacy as clearing IMGs’ route to practice, the National Institute of Mental Health sustains training programs for physician-scientists that could offer internationally trained psychiatrists academic footholds, and the American Psychiatric Association’s federal affairs arm has made workforce development a standing priority. The alternative to getting this right is a status quo the numbers render untenable. Every qualified psychiatrist kept out of the workforce is a caseload of untreated illness; every pathway built without safeguards risks the public trust on which all of medicine rests. The commentary’s title states the dilemma plainly — pitfalls and potential — and the country is about to discover how much of each it can afford.